Skip to content

The effect on an antidote to morphine on skin sensitivity around a heat injury

Effect of a late naloxone-infusion on secondary hyperalgesia after a first degree heat injury. - High dose naloxone: effect on secondary hyperalgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-005663-27-DK
Enrollment
Unknown
Registered
2013-02-27
Start date
2013-02-27
Completion date
Unknown
Last updated
2015-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

First degree burn injury in healthy volunteers MedDRA version: 14.1 Level: LLT Classification code 10020573 Term: Hyperalgesia System Organ Class: 100000004852

Interventions

Trade Name: Naloxone Pharmaceutical Form: Solution for injection/infusion INN or Proposed INN: NALOXONE CAS Number: 465-65-6 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal

Sponsors

HOC, Rigshospitalet
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: male, healthy, age between 20 and 35, BMI between 18 and 30, verbal and written informed consent, normal cardiac ultrasound examination, normal ECG Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 49 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: unable to cooperate, not able to understand Danish or English, neurological disease, psychiatric disease, drug or alcohol abuse, chronic pain state, positive urine test for opioids (morphine, methadone, buprenorphine), skin infection in the test areas (lower leg), allergy to morphine-related drugs, chronic pain medication.

Design outcomes

Primary

MeasureTime frame
Main Objective: The main objective is to evaluate if naloxone can re-instate secondary hyperalgesia areas 7 days after a burn injury;Secondary Objective: The secondary objective is to examine if naloxone can re-instate hyperalgesia, evaluated by thermal (warmth detection thresholds, heat pain thresholds) and mechanical (pin-prick thresholds) after a first degree burn injury. Psychometrics (Hospital Anxiety and Depression Scale [HADS], Pain Catastrophizing Scale [PCS]) and correlation with pain-related variables.;Primary end point(s): Primary outcome is areas of secondary hyperalgesia;Timepoint(s) of evaluation of this end point: Secondary hyperalgesia areas are evaluated before and 1,2,3,165,168 + 168½ hrs after the burn injury.

Secondary

MeasureTime frame
Secondary end point(s): Thermal and mechanical thresholds, and, psychometrics;Timepoint(s) of evaluation of this end point: Thermal thresholds are assessed at baseline and 1,2,3 hours after the burn injury. Mechanical thresholds are assessed at baseline and 1,2,3,165,168 + 168½ hrs after the burn injury. Psychometrics are obtained at baseline.

Countries

Denmark

Contacts

Public ContactDept. Anaesthesiology 4231, HOC

HOC, Rigshospitalet

joergen.b.dahl@rh.regionh.dk

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Mar 4, 2026